BPA and risk assessment
- PMID: 32197109
- PMCID: PMC7899191
- DOI: 10.1016/S2213-8587(20)30070-X
BPA and risk assessment
Comment in
-
BPA and risk assessment.Lancet Diabetes Endocrinol. 2020 Apr;8(4):270-271. doi: 10.1016/S2213-8587(20)30069-3. Lancet Diabetes Endocrinol. 2020. PMID: 32197111 No abstract available.
-
BPA and risk assessment - Authors' reply.Lancet Diabetes Endocrinol. 2020 Apr;8(4):271-272. doi: 10.1016/S2213-8587(20)30071-1. Lancet Diabetes Endocrinol. 2020. PMID: 32197112 No abstract available.
Comment on
-
BPA: have flawed analytical techniques compromised risk assessments?Lancet Diabetes Endocrinol. 2020 Jan;8(1):11-13. doi: 10.1016/S2213-8587(19)30381-X. Epub 2019 Dec 5. Lancet Diabetes Endocrinol. 2020. PMID: 31813841 No abstract available.
-
BPA and risk assessment.Lancet Diabetes Endocrinol. 2020 Apr;8(4):269. doi: 10.1016/S2213-8587(20)30068-1. Lancet Diabetes Endocrinol. 2020. PMID: 32197110 No abstract available.
References
-
- Gerona R, vom Saal FS, and Hunt PA, BPA: have flawed analytical techniques compromised risk assessments? Lancet Diabetes Endocrinol, 2020. 8(1): p. 11–13. - PubMed
-
- Teeguarden JG, et al., 24-hour human urine and serum profiles of bisphenol A: Evidence against sublingual absorption following ingestion in soup. Toxicology and Applied Pharmacology, 2015. 288(2): p. 131–142. - PubMed
-
- Volkel W, et al., Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chemical Research in Toxicology, 2002. 15(10): p. 1281–1287. - PubMed
-
- Buscher B, et al., Quantitative analysis of unconjugated and total bisphenol A in human urine using solid-phase extraction and UPLC-MS/MS: Method implementation, method qualification and troubleshooting. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2015. 1005: p. 30–38. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources